Objective:The purpose of this study was to explore the effect and mechanism of maternal chorioamnionitis on placental microvasculature and platelet activation among preterm infants by activating Wnt-Flt1 signal pathway . Methods:With clinical randomized controlled trial (RCT), the cases were matched with 1:1 according to gestational age and divided into 2 groups according to the placental pathology result: chorioamnionitis group and control group. (1) To observe the platelet parameter, birth weight, thrombrocytopenia and hemorrhage complication, such as intracranial hemorrhage, retinal hemorrhage, pulmonary hemorrhage and gastrointestinal hemorrhage. (2) To observe the miscrovascular density (MVD) in placenta, platelet activating factor (CD62p,CD63) and thrombopotetin (TPO) in preterrn infants.The placental MVD was assessed by immunohistochemical method. The platelet activating factors were detected by flow cytometry. TPO was detected by ELISA. (3) To observe Wnt5a, Flt1 and VEGF in placenta and fetal circulation.The measurement data were analyzed by pair t test and conditional logistic regression. Pearson correlation analysis was used for relationship.
The exclusive criteria included :(1) born to mother with no any other maternal complications; (2) no congenital abnormalities and neonatal asphyxia; (3) died or discharged within 72 hours.
Study Type
OBSERVATIONAL
Enrollment
64
It is a observation research. We didn't intervene anything. The chorioamnionitis groups included the infants whose mothers were diagnosed chorioamnionitis by placental histopathology.
Placental Microvascular Density(%)
Placental Microvascular Density (by placental histopathology)
Time frame: 24 hours
Incidence Hemorrhage Disease (%)
intraventricular hemorrhage (IVH), retinal hemorrhage, pulmonary hemorrhage and gastrointestinal hemorrhage
Time frame: through study completion, an average of half year
Wnt5a in Placenta(IOD)
by placental histopathology
Time frame: 24 hours
mean platelet volume(MPV)
MPV (Fl)
Time frame: 24 hours
platelet distribution width(PDW)
PDW (%)
Time frame: 24 hours
Platelet counts (PLT)
PLT (10\^9/L)
Time frame: 24 hours
Thrombopoietin (cord blood)
TPO(ng/ml)
Time frame: 24 hours
Platelets Activation Factors in cord blood
CD62p(%)
Time frame: 24 hours
Flt1 in Placenta(IOD)
by placental histopathology
Time frame: 24 hours
VEGF in Placenta(IOD)
by placental histopathology
Time frame: 24 hours
Wnt5 in infants (ng/ml)
test them by Elisa from cord blood
Time frame: 24 hours
Flt1 in infants (ng/ml)
test them by Elisa from cord blood
Time frame: 24 hours
VEGF in infants (ng/ml)
test them by Elisa from cord blood
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.